Long-acting muscarinic antagonists vs. long-acting β (2) agonists in COPD exacerbations: a systematic review and meta-analysis

OBJECTIVE: To determine whether long-acting muscarinic antagonists (LAMAs) provide superior therapeutic effects over long-acting β(2) agonists (LABAs) for preventing COPD exacerbations. METHODS: This was a systematic review and meta-analysis of randomized clinical trials involving patients with stab...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Israel Silva, Pincelli, Mariângela Pimentel, Leite, Victor Figueiredo, Amadera, João, Buehler, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687968/
https://www.ncbi.nlm.nih.gov/pubmed/28767773
http://dx.doi.org/10.1590/S1806-37562016000000287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687968/
https://www.ncbi.nlm.nih.gov/pubmed/28767773
http://dx.doi.org/10.1590/S1806-37562016000000287

Ejemplares similares